Ask AI

Comprehensive Strategies for Tardive Dyskinesia: Elevating Care Quality Across Clinical System

Dopamine receptor–blocking agents offer remarkable efficacy to patients with many psychiatric conditions but include a risk of developing a movement disorder known as tardive dyskinesia, which is often unrecognized. Awareness of this condition is key to effective monitoring and treatment, preventing this routine adverse event from negatively affecting patients’ quality of life.

Share

Program Content

Events

Activities

Psych Update APP 2026 TD
Elevating Tardive Dyskinesia Detection and Care: Comprehensive Strategies for APP
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 05, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Neurocrine Biosciences.

Neurocrine Biosciences